Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 366 | 1,509 | 2,448 | 1,463 | 2,584 |
| Receivables | 473 | 437 | 451 | 410 | 376 |
| Inventories | 573 | 486 | 425 | 472 | 537 |
| Other current assets | 113 | 70 | 93 | 114 | 316 |
| TOTAL | $1,525 | $2,501 | $3,417 | $2,459 | $3,812 |
| Non-Current Assets | |||||
| PPE Net | 1,048 | 1,107 | 1,116 | 1,196 | 803 |
| Other Non-Current Assets | 629 | 553 | 381 | 317 | 176 |
| TOTAL | $1,676 | $1,660 | $1,497 | $1,513 | $979 |
| Total Assets | $3,201 | $4,161 | $4,913 | $3,972 | $4,792 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 506 | 328 | 524 | 586 | 934 |
| Accrued Expenses | 393 | 267 | 246 | 333 | 380 |
| TOTAL | $987 | $681 | $853 | $988 | $1,335 |
| Non-Current Liabilities | |||||
| TOTAL | $364 | $387 | $404 | $425 | $0 |
| Total Liabilities | $1,351 | $1,068 | $1,257 | $1,413 | $1,335 |
| Shareholders' Equity | |||||
| Common Shares | 44,527 | 44,527 | 44,349 | 42,602 | 42,174 |
| Retained earnings | -60,078 | -58,452 | -57,564 | -56,039 | -54,794 |
| Other shareholders' equity | 5,860 | 5,643 | 5,569 | 4,723 | 5,089 |
| TOTAL | $1,850 | $3,093 | $3,656 | $2,559 | $3,457 |
| Total Liabilities And Equity | $3,201 | $4,161 | $4,913 | $3,972 | $4,792 |